Recent Finacing
Recent Raise
HiFiBiO uses single‑cell profiling with CelliGO and DIS platforms for single‑B‑cell antibody discovery, developing antibody drugs for oncology and autoimmune diseases and advancing candidates to clinical trials globally.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at HiFiBiO.
